Stock 8432 TSH BIOPHARM CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

TSH Biopharm Corporation Limited Stock

Equities

8432

TW0008432006

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-06-12 pm EDT 		5-day change 1st Jan Change
64 TWD -0.31% Intraday chart for TSH Biopharm Corporation Limited -4.62% +27.24%
May. 24 TSH Biopharm Corporation Limited Announces Appointment of Two Additional Members of Sustainable Development Committee CI
May. 24 TSH Biopharm Corporation Limited Announces Appointment of Two Additional Members of Audit Committee CI

Financials

Sales 2022 464M 14.35M Sales 2023 811M 25.06M Capitalization 1.93B 59.68M
Net income 2022 61M 1.89M Net income 2023 62M 1.92M EV / Sales 2022 2.38 x
Net cash position 2022 722M 22.32M Net cash position 2023 765M 23.63M EV / Sales 2023 1.44 x
P/E ratio 2022
29.5 x
P/E ratio 2023
31.2 x
Employees 76
Yield 2022
3.36%
Yield 2023
2.54%
Free-Float 34.75%
More Fundamentals * Assessed data

Chart TSH Biopharm Corporation Limited

Dynamic Chart

Latest news about TSH Biopharm Corporation Limited

TSH Biopharm Corporation Limited Announces Appointment of Two Additional Members of Sustainable Development Committee CI
TSH Biopharm Corporation Limited Announces Appointment of Two Additional Members of Audit Committee CI
TSH Biopharm Corporation Limited Appoints Two Additional Independent Directors CI
TSH Biopharm Corporation Limited Announces Cash Dividend for the Year 2023, Payable on July 12, 2024 CI
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024 CI
TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024 CI
TSH Biopharm Corporation Limited agreed to acquire an unknown stake in TOP Pharm. Medicalware Company Limited from Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd., ANIMATO INTERNATIONAL COMPANY, Shen Feng Co., Ltd. and others for TWD 257.1 million. CI
TSH Biopharm Corporation Limited agreed to acquire 51% stake in TOP Biological Technology Company Limited from Shen Feng Co., Ltd., Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd. ANIMATO INTERNATIONAL COMPANY and others for TWD 44.3 million. CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
TSH Biopharm Corporation Limited Announces the Change of Financial Officer, Effective on January 1, 2024 CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Tsh Biopharm Corporation Limited Announces the Change of Audit Committee Members CI
Tsh Biopharm Corporation Limited Announces Dividend for the Year 2022, Payable on July 14, 2023 CI
More news

Press releases TSH Biopharm Corporation Limited

TSH Biopharm : is invited to attend the online institutional investor conference hosted by IBF Securities PU
TSH Biopharm : Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2022 PU
TSH Biopharm : Announcement of setting up the Sustainable Development Committee and members of TSH's first Sustainable Development Committee PU
TSH Biopharm : was invited to attend the online institutional investor conference hosted by Concord Securities PU
TSH Biopharm : Announcement of Change to Remuneration Committee member PU
More press releases

Quotes and Performance

1 day-0.31%
1 week-4.62%
Current month+2.56%
1 month-0.47%
3 months+12.68%
6 months+30.35%
Current year+27.24%
More quotes

Highs and lows

1 week
63.90
Extreme 63.9
68.20
1 month
61.40
Extreme 61.4
68.70
Current year
49.10
Extreme 49.1
69.20
1 year
44.30
Extreme 44.3
69.20
3 years
38.80
Extreme 38.8
69.20
5 years
38.80
Extreme 38.8
82.50
10 years
34.95
Extreme 34.95
114.50
More quotes

Managers and Directors - TSH Biopharm Corporation Limited

Managers TitleAgeSince
Ssu Yuan Yang CEO
 Chief Executive Officer - -
Chen Ju Kan DFI
 Director of Finance/CFO - 10-08-31
Shu Ping Huang ADM
 Chief Administrative Officer - 10-08-31
Members of the board TitleAgeSince
Kang Chi Chou BRD
 Director/Board Member - -
Chuan Lin CHM
 Chairman 72 -
Hsin Yang Liu PRN
 Corporate Officer/Principal - -
More insiders

Quotes

Date Price Change Volume
24-06-14 63.5 -0.78% 145,713
24-06-13 64 -0.31% 121,128
24-06-12 64.2 -3.75% 298,831
24-06-11 66.7 +0.60% 179,154
24-06-07 66.3 -1.19% 201,488

End-of-day quote Taipei Exchange, June 12, 2024

More quotes

Company Profile

Tsh biopham corporation ltd. is a Taiwan-based company principally engaged in the manufacturing and distribution of medical preparations. The Company primarily provides medicines for cardiovascular, including Amtrel, Rytmonorm, Licodin, Isormol and ISOPTIN SR; medicines for intestines and stomach, including MOPRIDE, Catilon, Gastro-Timelet and Ribarin, and medicines for central nervous, including Aleviatin, Lonine and Lacoxa SR. The Company distributes its products mainly in domestic markets.
Sector
Pharmaceuticals
Calendar
2024-07-31 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

1st Jan change Capi.
TSH BIOPHARM CORPORATION LIMITED Stock TSH Biopharm Corporation Limited
+27.24% 75.88M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+51.54% 795B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.20% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.67% 328B
ABBVIE INC. Stock AbbVie Inc.
+7.48% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.92% 245B
ROCHE HOLDING AG Stock Roche Holding AG
+1.35% 222B
NOVARTIS AG Stock Novartis AG
+11.78% 215B
AMGEN INC. Stock Amgen Inc.
+3.64% 160B
PFIZER, INC. Stock Pfizer, Inc.
-3.96% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 8432 Stock